Actively Recruiting
Magnetocardiography in the Accurate Identification of Myocardial Infarction
Led by Qilu Hospital of Shandong University · Updated on 2025-10-02
3841
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
Sponsors
Q
Qilu Hospital of Shandong University
Lead Sponsor
C
Chongqing Emergency Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
Magnetocardiography (MCG) is a promising noninvasive and accurate method for detecting myocardial infarction. Although progress has been made in this area, there is a lack of studies using up-to-date examination instruments for the calibration of MCG analysis. This is a prospective single-center study aiming to build accurate analytical models of MCG to detect myocardial infarction. Myocardial infarction are diagnosed by electrocardiogram, biomarkers (high-sensitivity cardiac troponin, etc), or non-invasive imaging (cardiac magnetic resonance or single-photon-emission tomography). Myocardial infarction is also quantified by cardiac magnetic resonance or single-photon-emission tomography. Healthy volunteers and chest pain patients who will receive electrocardiogram, biomarkers (high-sensitivity cardiac troponin, etc), or non-invasive imaging (cardiac magnetic resonance or single-photon-emission tomography) examination will be enrolled in this study.
CONDITIONS
Official Title
Magnetocardiography in the Accurate Identification of Myocardial Infarction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 79 years old
- Healthy volunteers with no history of cardiovascular disease or risk factors (with some controlled exceptions for those over 65)
- Normal electrocardiogram and cardiac ultrasound within the past year for healthy volunteers
- Chest pain patients diagnosed or suspected of stable or unstable angina or myocardial infarction, planned for ECG, biomarker, or non-invasive imaging
- Signed informed consent
You will not qualify if you...
- Acute or chronic respiratory diseases
- Abnormal liver or kidney function
- Endocrine diseases such as abnormal thyroid function
- Anemia or other blood diseases
- Connective tissue diseases with or without cardiac complications
- Obesity (BMI >30 kg/m2) or underweight (BMI <18 kg/m2)
- Malignant tumors
- Infectious diseases
- Trauma or physical disability
- Psychological or mental illness such as depression
- Professional athletes, pregnant or breastfeeding women, alcoholics
- Unable to perform or failed magnetocardiography due to claustrophobia or physical impairment
- Allergy to contrast agents or metal implants preventing MRI or research procedures
- Known structural heart disease or arrhythmias not returned to normal
- Acute or severe illnesses in other systems
- Failure to cooperate with research requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012
Actively Recruiting
Research Team
J
Jiaojiao Pang, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here